Full List Of Stories
Travel and leisure, and technology issues weighed on Europe's main stockmarket gauges, although a positive start to the US second-quarter corporate reporting season helped to stem losses.
The European Union will not expand its list of countries allowed restriction-free travel when officials meet for their bi-weekly review.
Shares of US drug developer Rigel Pharmaceuticals shot higher on news that researchers at Imperial College were set to launch a clinical trial into the use of one of its existing treatments to help patients suffering from mild-to-moderate Covid-19 pneumonia from worsening.
The cost of living in the US increased slightly more quickly than anticipated amid broad gains in prices by categories.
Stocks in Europe are holding lower despite news of a positive start to the US second-quarter corporate reporting season.
Chinese foreign trade moved up a gear in June, belying a strong domestic economy and overseas.
A stronger-than expected reading for a widely-followed gauge of small business confidence in June was misleading, some economists said.
Investors will be closely watching Tuesday morning's data release on UK gross domestic product, following a 20. 4% plunge that pushed the country's economic output down to levels last seen in 2002.
Stocks in Europe have started the morning down, tracking a sharp intra-day reversal lower in US stocks overnight after authorities in the state of California reversed the opening of bars and restaurants in response to the growing number of novel coronavirus infections.
Stocks in Europe finished the session at their best level in over a month ahead of the start of the second quarter earnings season, even as the single currency continued to bound higher.
Equity strategists at Morgan Stanley sounded a positive note on so-called 'value' stocks, arguing that the economic cycle was shifting into a 'recovery regime' - but there was catch.
Libya is set to resume crude oil exports in the wake of successful talks between the country's two warring factions following talks led by the United Nations and the United States.
Equity strategists at JP Morgan believe that second quarter corporate results on both sides of the Atlantic may come in ahead of analysts' forecasts, helped by the fact that estimates were at very depressed levels.
Stocks in Europe are bumping up against multi-month highs at the beginning of the second quarter earnings season on both sides of the Atlantic, despite some analysts' reservations, helped by more positive news around efforts to develop a Covid-19 vaccine.
Stocks in Europe have started the week higher with investors opting to take a 'glass half full' approach and with investor sentiment boosted further by gains during Asian trading and merger news on both sides of the Atlantic.
The focus over the coming week will be on reports covering gross domestic product and the labour market in May.
The Sunday Times's Sabah Meddings told readers of her 'Inside the City' column to 'buy' shares of PureTech, citing the the drug maker's ingenious 'portfolio' approach and ample pipeline of treatments in various phases of development.
Taxes and red tape will be slashed in towns and cities across the country next year, under government plans for a post-Brexit and post-coronavirus economic revolution. Rishi Sunak, the Chancellor, is preparing to introduce sweeping tax cuts and an overhaul of planning laws in up to 10 new "freeports" within a year of the UK becoming fully independent from the European Union in December, The Telegraph can reveal. - Sunday Telegraph.
Gains for lenders' shares and among Technology stocks saw Europe's main stockmarket gauges finish the week on an up note, with the latter extending their breakout to multi-year highs.
London's second-tier index notched up a gain of 0. 76% in the final session of the week to 6,095. 41.